These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3709269)

  • 1. Azlocillin serum levels on repetitive dosage in patients with normal and abnormal renal function.
    Wenk M; Follath F
    Chemotherapy; 1986; 32(3):205-8. PubMed ID: 3709269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetic studies of azlocillin in pregnancy].
    Voigt R; Patsch R; Schröder S; Peiker G; Brandstädt A
    Z Geburtshilfe Perinatol; 1985; 189(2):88-90. PubMed ID: 4013451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of azlocillin in children with and without cystic fibrosis treated for infectious diseases.
    Michalsen H; Bergan T
    Methods Find Exp Clin Pharmacol; 1986 Dec; 8(12):727-9. PubMed ID: 3807473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Azlocillin in the treatment of pulmonary infections in patients with cystic fibrosis: plasma concentrations and therapeutic indications].
    Rosselli P; Marianelli L; Valenza T; Bartolozzi G
    Pediatr Med Chir; 1989; 11(4):389-91. PubMed ID: 2694104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of azlocillin in normal renal function: single and repetitive dosing studies.
    Delgado FA; Stout RL; Whelton A
    J Antimicrob Chemother; 1983 May; 11 Suppl B():79-88. PubMed ID: 6619035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azlocillin versus azlocillin plus amikacin in the treatment of severe infections in intensive care unit patients.
    Mergoni M; Stocchetti N; De Cristofaro A; Antonioni M; Zuccoli P
    Chemioterapia; 1987 Aug; 6(4):286-9. PubMed ID: 3652280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple-dose pharmacokinetics of piperacillin and azlocillin in 12 healthy volunteers.
    Tartaglione TA; Nye L; Vishniavsky N; Poynor W; Polk RE
    Clin Pharm; 1986 Nov; 5(11):911-6. PubMed ID: 3780161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic interactions between azlocillin, cefotaxime, and cefotaxime metabolites in normal and impaired renal function.
    Kampf D; Borner K; Möller M; Kessel M
    Clin Pharmacol Ther; 1984 Feb; 35(2):214-20. PubMed ID: 6319069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The pharmacokinetics of azlocillin after single and multiple intravenous injections during the third trimester].
    Voigt R; Weidt I; Schröder S; Brandstädt A; Peiker G
    Zentralbl Gynakol; 1988; 110(15):944-8. PubMed ID: 3055753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetics of azlocillin in chronic renal failure and hemodialysis patients].
    Fillastre JP; Humbert G; Leroy A; Godin M
    Presse Med; 1984 Mar; 13(13):797-801. PubMed ID: 6231597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of single-agent therapy with azlocillin, ticarcillin, and amikacin and beta-lactam/amikacin combinations for treatment of Pseudomonas aeruginosa bacteremia in granulocytopenic rats.
    Johnson DE; Thompson B
    Am J Med; 1986 May; 80(5C):53-8. PubMed ID: 3636060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of azlocillin in persons with normal and impaired renal functions.
    Fiegel P; Becker K
    Antimicrob Agents Chemother; 1978 Sep; 14(3):288-91. PubMed ID: 708008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of the pharmacokinetics and dose dependency of azlocillin in normal subjects and patients with renal insufficiency.
    Bergan T
    J Antimicrob Chemother; 1983 May; 11 Suppl B():101-14. PubMed ID: 6352598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azlocillin and mezlocillin concentration in human prostatic tissue.
    Smith RP; Wilbur HJ; Bassey C; Baltch AL
    Chemotherapy; 1988; 34(4):267-71. PubMed ID: 3208544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of high-dose azlocillin sodium in patients with cystic fibrosis.
    Woolf RA; Koup JR; Smith AL; Hilman BC; Goldmann D; Williams-Warren J
    Clin Pharm; 1985; 4(6):664-9. PubMed ID: 4075734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of azlocillin in healthy subjects.
    Leroy A; Humbert G; Fillastre JP
    Scand J Infect Dis Suppl; 1981; 29():49-54. PubMed ID: 6947405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo efficacy of azlocillin and amikacin versus ciprofloxacin with and without amikacin in experimental right-sided endocarditis due to Pseudomonas aeruginosa.
    Bayer AS; Kim KS
    Chemotherapy; 1986; 32(4):364-73. PubMed ID: 2942342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of infusion rate on pharmacokinetic parameters of azlocillin and mezlocillin].
    Haen E; Remien J; Richter E; Frank U; Adam D
    Arzneimittelforschung; 1985; 35(5):864-8. PubMed ID: 4026911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical pharmacokinetics of azlocillin].
    Singlas E; Haegel C
    Presse Med; 1984 Mar; 13(13):788-96. PubMed ID: 6231596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azlocillin, cephalothin, and tobramycin therapy in febrile solid tumor patients with chemotherapy-induced leukopenia.
    Lowenbraun S; Fox N; Cunitz D
    Cancer; 1987 Jul; 60(1):14-7. PubMed ID: 3581029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.